NorthWest Biotherapeutics Inc (NWBO)

[Maverick0408]

They are here out of altruism and don’t care about the return on investment and importantly opportunity cost.

As I stated earlier, 2023 will be another lost year. The loyal supporters would like us to buy into one of the theories detailed below while the management continues to be ambiguous and keep shareholders in the dark to avoid mass exodus for their lack of meaningful progress:

1) The focus has shifted to FDA now? UK not number one priority anymore. So need more time to line up CRL and other million BLA pages?

2) Now applying strategically via Project Orbis. All RAs at once. Need extra months.

3) Flaskworks certification given off label demand considerations!

4) Tissue agnostic approvals.

5) No MAA acceptance PR. Need to wait until final MHRA approval (in 2024?) for the big reveal!